Literature DB >> 75978

Purification and immunologic evaluation of human melnoma-associated antigens.

R P McCabe, S Ferrone, M A Pellegrino, D H Kern, E C Holmes, R A Reisfeld.   

Abstract

Melanoma-associated antigens (MAA) were isolated and their functional immunologic properties were evaluated. Spent fetal calf serum-free culture media and 3-m KCI extracts of cultured human melanoma cells grown in this medium were used as antigen sources. Ultracentrifugal flotation on KBr was used to separate MAA and HLA antigens present in the extracts or spent culture media; thus interference by histocompatibility antigens was prevented in subsequent tests of tumor antigenic activity. MAA purified in this manner retained their immunologic functions as evidenced by their ability to produce delayed cutaneous hypersensitivity reactions in patients with melanoma, specifically combine with antimelanoma xenoantibody, and elicit production of functionally specific xenoantibody. Possible structural differences between HLA antigens and MAA were considered in evaluation of the data.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75978     DOI: 10.1093/jnci/60.4.773

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.

Authors:  K K Hunt; M Shibata; R K Gupta; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.

Authors:  D R Vlock; J M Kirkwood
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

3.  Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.

Authors:  T Tanaka; H Yamagishi; N R Pellis; B D Kahan
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Characterization of immunologically significant unique B16 melanoma proteins produced in vivo and in vitro.

Authors:  D M Gersten; V J Hearing; J J Marchalonis
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Cultivation of human osteosarcoma cell lines in serum-free hormone supplemented medium.

Authors:  K Y Tsang; H H Fudenberg; D C Sun; G S Pai; L R Bishop; S Sager
Journal:  In Vitro       Date:  1983-07

Review 6.  Noncytolytic extraction of cell surface antigens using butanol.

Authors:  S J LeGrue
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

7.  Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; S Watanabe; T Masaoka; K Takatsuki; M Kishihara; N Kobayashi; M Hattori; T Fujita
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

8.  Immunochemical delineation of an oncofetal antigen on normal and simian virus 40-transformed human fetal melanocytes.

Authors:  A C Morgan; D R Galloway; F C Jensen; B C Giovanella; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

9.  Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.

Authors:  D R Vlock; D Scalise; N Meglin; J M Kirkwood; B Ballou
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Further characterization of a melanoma-specific protein from human urine.

Authors:  C Bennett; K B Cooke
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.